Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Research article

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Robert D Inman* and Basil Chiu

Arthritis Research & Therapy 2012, 14:R150  doi:10.1186/ar3886

Accesses  

  • Last 30 days: 42 accesses
  • Last 365 days: 784 accesses
  • All time: 2462 accesses